Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Disease detectives: tracking invisible killers
Disease detectives on the frontlines of coronavirus track the person-to-person spread.
Chinese coronavirus vaccine advances to next trial phase
CanSino Bio’s Ad5-nCoV was the first Chinese coronavirus vaccine to be tested in humans. Now it’s the first in the world to enter Phase II trials.
Treating depression at home with a tDCS headset
At-home tDCS headsets are helping people treat their depression without having to go to a doctor’s office.
Modifying the measles vaccine could stop the coronavirus faster
To stop the coronavirus from spreading, researchers are working on a vaccine that would use the measles vaccine as its delivery vehicle.
Scientists find a way to quickly ID coronavirus mutations
A new tool that allows scientists to quickly identify coronavirus mutations could help experts track and treat COVID-19.
The rise of simulated sports in the face of COVID-19
Because of the coronavirus, sports have come to a screeching halt. Unless you look online.
Contact-tracing tech advances, the new saliva test, and more COVID-19 updates
In our weekly news roundup, we take you inside the fight against COVID-19 to explore the solutions on the frontlines of an unprecedented global response.
Lab plans to ship 20 million coronavirus antibody tests per month
Abbott Laboratories is shipping millions of coronavirus antibody tests to hospitals and labs across the United States.
FDA approves first saliva test for coronavirus
The FDA has granted a saliva test for coronavirus emergency use authorization, giving health officials a new way to diagnose COVID-19.
Could VR change how you trip on ketamine?
Virtual reality meets ketamine therapy to help treat pain, anxiety, and depression, to name a few.
Hong Kong protests in Animal Crossing
Hong Kong’s virtual protests, tech giants joining forces to slow the spread of COVID-19, and more top stories in our weekly Progress Report.
Major League Baseball joins massive coronavirus antibody study
More than 10,000 Major League Baseball players and employees agreed to have their blood tested for a massive coronavirus antibody study.
Major drugmakers team up on potential coronavirus vaccine
Major vaccine developers GlaxoSmithKline and Sanofi are collaborating on a potential coronavirus vaccine to help end the COVID-19 pandemic.
Doctors use AI to test new coronavirus treatments on patients
The University of Pittsburgh Medical Center launched a new trial that uses artificial intelligence to test promising coronavirus treatments as quickly as possible.
Across America, libraries are fighting the coronavirus
Communities are using every resource available to fight the coronavirus. Across the country, libraries are using their resources and staff to join the battle.
Why scientists are turning the coronavirus’ structure into music
MIT scientists have translated a key part of the coronavirus’ structure into music — and the song could help researchers find a way to stop the virus.
Apple and Google join forces on coronavirus tracking project
Apple and Google are collaborating on a coronavirus tracking project they hope will eliminate the privacy concerns surrounding contact-tracing apps.
It's safe to order takeout during the coronavirus pandemic. here's why.
Many experts agree that you can safely order takeout during the coronavirus pandemic — you just need to follow these steps.
Mobile decontamination units could extend supply of PPE
To extend the supply of PPE at hospitals during the coronavirus pandemic, a team of engineers transformed a shipping container into a decontamination unit.
Learning from disaster: An interview with Bryan Walsh
Human history is dotted with pandemics. We spoke with “End Times” author Bryan Walsh on how we can learn from them for the future.
Subscribe to the newsletter